The present invention relates to novel substituted tetrahydroisoquinoline compounds, pharmaceutical compositions containing the compounds, methods of making the compounds, and methods of using the compounds to destroy a target cell, such as a cancer cell, and to treat or prevent a cancerous condition.
This application claims the benefit of U.S. Provisional Patent Application Ser. No. 60/363,952, filed Mar. 13, 2002, which is hereby incorporated by reference in its entirety.
